Premenopausal serum androgens and breast cancer risk: a nested case-control study (Q36393224)

13 August 2017

Premenopausal serum androgens and breast cancer risk: a nested case-control study (English)

1 reference

13 August 2017

Anne Zeleniuch-Jacquotte

series ordinal

1

1 reference

13 August 2017

3

Rudolf Kaaks

1 reference

13 August 2017

9

Roy E Shore

1 reference

13 August 2017

4

Sabina Rinaldi

1 reference

13 August 2017

7

Alan A Arslan

1 reference

13 August 2017

10

Karen L Koenig

1 reference

13 August 2017

5

Stephanie Scarmo

1 reference

13 August 2017

Yelena Afanasyeva

2

1 reference

13 August 2017

Mengling Liu

series ordinal

6

1 reference

13 August 2017

Paolo Toniolo

series ordinal

8

1 reference

13 August 2017

16 February 2012

1 reference

13 August 2017

Breast Cancer Research

1 reference

13 August 2017

14

1 reference

13 August 2017

1

1 reference

13 August 2017

R32

1 reference

Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Prospective case-control study of premenopausal serum estradiol and testosterone levels and breast cancer risk

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography–tandem mass spectrometry

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

The Role of Androgens in Normal and Malignant Breast Tissue

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Prevalence of tamoxifen use for breast cancer chemoprevention among U.S. women.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Analysis of estrogens in serum and plasma from postmenopausal women: past present, and future

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Plasma sex hormone concentrations and breast cancer risk in an ethnically diverse population of postmenopausal women: the Multiethnic Cohort Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Mammary gland and endometrial effects of testosterone in combination with oral estradiol and progesterone

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Testosterone for low libido in postmenopausal women not taking estrogen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Risk prediction models with incomplete data with application to prediction of estrogen receptor-positive breast cancer: prospective data from the Nurses' Health Study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Measurement of androgens in women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Several anthropometric measurements and breast cancer risk: results of the E3N cohort study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Plasma adrenal androgens and risk of breast cancer in premenopausal women.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Testosterone effects on the breast: implications for testosterone therapy for women.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

A physiologic role for testosterone in limiting estrogenic stimulation of the breast

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Chemoprevention of breast cancer: recommendations and rationale

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Roles of androgens in the development, growth, and carcinogenesis of the mammary gland

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies

30 September 2017

1 reference

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition

21 January 2018

1 reference

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women

21 January 2018

1 reference

Circulating steroid hormone levels and risk of breast cancer for postmenopausal women

21 January 2018

1 reference

Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)

21 January 2018

1 reference

Endogenous sex hormones and subsequent breast cancer in premenopausal women

21 January 2018

1 reference

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

21 January 2018

1 reference

The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women

21 January 2018

1 reference

Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort

21 January 2018

1 reference

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women

21 January 2018

1 reference

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk

21 January 2018

1 reference

Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate

21 January 2018

1 reference

Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: a randomized trial

21 January 2018

1 reference

Influence of estrogen plus testosterone supplementation on breast cancer

21 January 2018

1 reference

Validity of free testosterone and free estradiol determinations in serum samples from postmenopausal women by theoretical calculations

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Reliability and validity of commercially available, direct radioimmunoassays for measurement of blood androgens and estrogens in postmenopausal women

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Endogenous hormones and breast cancer: a prospective cohort study

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Combined Estrogen and Testosterone Use and Risk of Breast Cancer in Postmenopausal Women

21 October 2018

1 reference

Comparison of active and cancer registry-based follow-up for breast cancer in a prospective cohort study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3496150

Sex hormone levels in serum in relation to the development of breast cancer

21 October 2018

1 reference

12 December 2020

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

12 December 2020

Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk?

1 reference

12 December 2020

Breast cancer prevention: patient decision making and risk communication in the high risk setting

1 reference

12 December 2020

Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period

1 reference

12 December 2020

Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women

1 reference

12 December 2020

A prospective study of endogenous hormones and breast cancer

1 reference

12 December 2020

Prescription of tamoxifen for breast cancer prevention by primary care physicians

1 reference

12 December 2020

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women

1 reference

12 December 2020

American Cancer Society guidelines for the early detection of cancer

1 reference

12 December 2020

Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women

1 reference

12 December 2020

A prospective study of estradiol and breast cancer in Japanese women

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR3117

1 reference

Dimensions Publication ID

13 August 2017

0 references

1 reference

13 August 2017

PubMed publication ID

22339988

1 reference